Labcorp stock: Labcorp declares USD 0.72 dividend for Labcorp stock

Published on 10/23/2026 at 01:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Labcorp declared a USD 0.72 dividend on October 21, 2026. Labcorp stock pays December 11, 2026, with November 24 as record date.

Dividend and reporting dates

Labcorp declared a USD 0.72 quarterly dividend on October 21, 2026.
Labcorp agreed to acquire BioReference assets for USD 722 million on October 15, 2026.
Labcorp is scheduled to report third-quarter results on October 28, 2026.

Aquarellbild eines gläsernen Bürogebäudes vor Skyline in Pastelltönen — Aquarellmalerei einer Stadtlandschaft mit gläsernem Firmensitz symbolisiert Labcorp, ISIN US50540R4092, im Gesundheitssektor, Illustration mit AI erstellt.

Labcorp Holdings Inc. (ISIN US5049221055) declared a quarterly dividend of USD 0.72 per share on October 21, 2026. According to MarketBeat, the payment is scheduled for December 11, 2026, for shareholders of record on November 24, 2026.

Dividend points to low payout

The declared payment represents USD 2.88 on an annualized basis. MarketBeat reported a 16.4 percent payout ratio on October 21, 2026, giving the dividend a defined earnings buffer rather than making it the main earnings story.

Three October developments

Labcorp's recent sequence began on October 15, 2026, when it agreed with OPKO Health to acquire selected BioReference Health assets for USD 722 million in cash, plus a possible USD 150 million earnout, according to MarketScreener. On October 20, 2026, Labcorp agreed to buy Myriad Genetics' prenatal testing business for USD 210 million, with expected first-year revenue of USD 160 million, as reported by AFX News. The October 21 dividend declaration is the latest event.

What date comes next

Labcorp is scheduled to release third-quarter 2026 results before the market opens on October 28, 2026, and to host its earnings webcast at 9:00 a.m. ET, according to the company's Labcorp release dated September 30, 2026. The latest reported second-quarter revenue was USD 3.73 billion, up 5.8 percent year over year, while adjusted earnings per share reached USD 4.99, according to MarketBeat's October 21, 2026 report.

Stock context before results

Labcorp had a USD 26.8 billion market capitalization on October 22, 2026, while its primary-exchange 52-week range was USD 244.52 to USD 341.80. The last available euro quote stood at EUR 288.00 on Tradegate on October 21, 2026 at 4:33 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Labcorp stock.